Document Detail

The effect of self-licking behavior on pharmacokinetics of eprinomectin and clinical efficacy against Psoroptes cuniculi in topically administered rabbits.
MedLine Citation:
PMID:  20069313     Owner:  NLM     Status:  MEDLINE    
Ear mange mite Psoroptes cuniculi, one of the predominant parasites in rabbits, can cause considerable weight loss, low favorable fee conversion rates, and meningitis. The present experiment was to investigate the difference of plasma disposition and the variation of clinical efficacy under the effect of animal self-licking behavior in topically administered rabbits. Ten rabbits for pharmacokinetic study in two groups (the self-licking and the nonlicking)were topically administered with 1 mg kg(-1) of eprinomectin. In the self-licking group, rabbits were allowed to self-lick freely, while, to prevent self-licking, each animal in the non-licking group was fitted with a pet collar. Compared to the non-licking group, self-licking behavior contributed to an extremely significant shorter half-life of absorption (14.85+/-2.79 h in licking group vs.29.44+/-7.81 h in non-licking group, p<0.01) and an extremely significant higher C(max) value for eprinomectin (21.95+/-5.36 h in licking group vs. 6.98+/-0.72 ng ml(-1) in non-licking group, p<0.01) in plasma disposition. An extremely significantly shorter mean residence time (50.72+/-3.45 h) in self-licking group was also determined compared with the value obtained in non-licking group (106.66+/-7.39 h; p<0.01). Clinical efficacy study of eprinomectin was examined in rabbits naturally infested with P. cuniculi which were randomly allocated in three groups: the self-licking, the non-licking, and control groups. All rabbits in the self-licking and the non-licking groups were treated with topical eprinomectin at a single dose of 2 mg kg(-1) (day 0). Topical eprinomection led to a complete parasitological recovery in both treated groups on day 14 and remained free of live mites and clinical lesions from day 21 to the end of the study period (day 35).
Huiqiang Wen; Baoliang Pan; Fangfei Wang; Zhenzhong Yang; Zhujun Wang; Shuai Liu; Ming Wang
Related Documents :
12678413 - Pancreatic concentrations of cefepime in experimental necrotizing pancreatitis.
1598513 - Effect of ivermectin on experimental gnathostomiasis in rabbits.
10064163 - Eeg burst suppression is not necessary for maximum barbiturate protection in transient ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Parasitology research     Volume:  106     ISSN:  1432-1955     ISO Abbreviation:  Parasitol. Res.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-18     Completed Date:  2010-04-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703571     Medline TA:  Parasitol Res     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  607-13     Citation Subset:  IM    
College of Veterinary Medicine, Key Laboratory of Development and Evaluation of the Chemical and Herbal Drugs for Animal Use, China Agricultural University, 100193 Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Insecticides / administration & dosage,  pharmacokinetics*,  therapeutic use*
Ivermectin / administration & dosage,  analogs & derivatives*,  pharmacokinetics,  therapeutic use
Mite Infestations / drug therapy,  veterinary*
Plasma / chemistry
Psoroptidae / drug effects*
Time Factors
Treatment Outcome
Reg. No./Substance:
0/Insecticides; 160902-72-7/4''-epiacetylamino-4''-deoxyavermectin B1; 70288-86-7/Ivermectin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sarcoplasmic reticulum Ca2+ depletion in adult skeletal muscle fibres measured with the biosensor D1...
Next Document:  Catheter-free methods for vesicoureteric reflux detection: our experience and a critical appraisal o...